Idebenone 58186-27-9

Idebenone (pronounced eye-deb-eh-known, trade names Catena and Sovrima) is an experimental drug, initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. {{as of

read more [+]

Systematic (IUPAC) name:	2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-cyclohexa-2,5-diene-1,4-dione
Idebenone CAS number:	58186-27-9
ATC code:	N06BX13
PubChem:	3686
DrugBank:
Formula:	C19H30O5
Molecular mass:	338.439 g/mol
Idebenone Assay/Purity:	Typically NLT 98%

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.